AMGEN is a wholesaler in Machelen (Brab.). Public Limited, started on 21 December 1989, 1 establishment.

What is the address of AMGEN?

The registered office of AMGEN is located at Telecomlaan 5-7, 1831 Machelen (Brab.).

Is AMGEN still active?

Yes. According to the CBE (29 October 2026) AMGEN is active, legal situation “Normale toestand”, started on 21 December 1989.

Is AMGEN registered on Peppol?

Yes, AMGEN is registered on the Peppol network with ID 0208:0439652401.

What is the enterprise number of AMGEN?

The enterprise number of AMGEN is BE0439652401.

When was AMGEN founded?

AMGEN was founded on 21 December 1989.

Who are the directors of AMGEN?

According to the 2025 annual accounts, the directors of AMGEN are: Sara Schaufelberger, Paraskevi Florou, Roman Stampfli.

Is AMGEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 December 1989; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did AMGEN make in 2025?

AMGEN posted a profit after taxes of € 5,951,405 in financial year 2025.

What is the revenue of AMGEN?

In its most recent annual accounts (2025), AMGEN reported revenue of € 195,933,782.

How much does an employee at AMGEN earn?

The average wage cost per full-time employee at AMGEN was € 202,200 in 2025: staff costs of € 19.1 million for 94.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does AMGEN have?

According to the 2025 annual accounts, AMGEN has 94.7 full-time equivalents (FTE).

AMGEN (Public Limited) - Machelen (Brab.) - BE0439652401

Dossier AMGEN, printed on 29 October 2026 from databakkes.be/en/0439652401/amgen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

AMGEN from Machelen (Brab.), company number BE0439652401, closed financial year 2025 with a result of € 6 million after tax. For that financial year AMGEN recorded revenue of € 195.9 million and equity of € 6.8 million. Compared with financial year 2024, the result moved from € 5.6 million to € 6 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Growing

€ 6.8 million

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 6 million

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2,667

▲ 118% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 5 million paid out

84 % of the profit went to the shareholders, mostly to Amgen Worldwide Holdings BV (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

94.7

▼ 3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 18.3 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 19.1 million

▲ 1% vs 2024

€ 202,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 62,478

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 30.9 million

▲ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 87 days on average.

Taxes and wages

€ 3.9 million

▲ 12% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 144,568,084 Revenue 2022: € 144,568,084 First fiscal year in the series	€ 147,145,913 Revenue 2023: € 147,145,913 ▲ 2% vs 2022 (€ 144,568,084) Favourable step	€ 175,558,223 Revenue 2024: € 175,558,223 ▲ 19% vs 2023 (€ 147,145,913) Favourable step	€ 195,933,782 Revenue 2025: € 195,933,782 ▲ 12% vs 2024 (€ 175,558,223) Favourable step	▲ 12%
Profit after taxes	€ 4,965,989 Profit after taxes 2022: € 4,965,989 First fiscal year in the series	€ 4,468,577 Profit after taxes 2023: € 4,468,577 ▼ 10% vs 2022 (€ 4,965,989) Unfavourable step	€ 5,638,840 Profit after taxes 2024: € 5,638,840 ▲ 26% vs 2023 (€ 4,468,577) Favourable step	€ 5,951,405 Profit after taxes 2025: € 5,951,405 ▲ 6% vs 2024 (€ 5,638,840) Favourable step	▲ 6%
Equity	€ 8,258,429 Equity 2022: € 8,258,429 First fiscal year in the series	€ 7,727,006 Equity 2023: € 7,727,006 ▼ 6% vs 2022 (€ 8,258,429) Unfavourable step	€ 5,865,846 Equity 2024: € 5,865,846 ▼ 24% vs 2023 (€ 7,727,006) Unfavourable step	€ 6,817,251 Equity 2025: € 6,817,251 ▲ 16% vs 2024 (€ 5,865,846) Favourable step	▲ 16%
Total debts	€ 37,986,994 Total debts 2022: € 37,986,994 First fiscal year in the series	€ 33,487,017 Total debts 2023: € 33,487,017 ▼ 12% vs 2022 (€ 37,986,994) Favourable step	€ 32,189,512 Total debts 2024: € 32,189,512 ▼ 4% vs 2023 (€ 33,487,017) Favourable step	€ 37,251,335 Total debts 2025: € 37,251,335 ▲ 16% vs 2024 (€ 32,189,512) Unfavourable step	▲ 16%
Cash	€ 1,222 Cash 2022: € 1,222 First fiscal year in the series	€ 1,913 Cash 2023: € 1,913 ▲ 57% vs 2022 (€ 1,222) Favourable step	€ 1,222 Cash 2024: € 1,222 ▼ 36% vs 2023 (€ 1,913) Unfavourable step	€ 2,667 Cash 2025: € 2,667 ▲ 118% vs 2024 (€ 1,222) Favourable step	▲ 118%
Retained profit	€ 8,084,904 Retained profit 2022: € 8,084,904 First fiscal year in the series	€ 7,553,480 Retained profit 2023: € 7,553,480 ▼ 7% vs 2022 (€ 8,084,904) Unfavourable step	€ 5,692,320 Retained profit 2024: € 5,692,320 ▼ 25% vs 2023 (€ 7,553,480) Unfavourable step	€ 6,643,725 Retained profit 2025: € 6,643,725 ▲ 17% vs 2024 (€ 5,692,320) Favourable step	▲ 17%
Dividend	€ 13,000,000 Dividend 2022: € 13,000,000 First fiscal year in the series	€ 5,000,000 Dividend 2023: € 5,000,000 ▼ 62% vs 2022 (€ 13,000,000) Unchanged	€ 7,500,000 Dividend 2024: € 7,500,000 ▲ 50% vs 2023 (€ 5,000,000) Unchanged	€ 5,000,000 Dividend 2025: € 5,000,000 ▼ 33% vs 2024 (€ 7,500,000) Unchanged	▼ 33%
Balance sheet total	€ 46,249,347 Balance sheet total 2022: € 46,249,347 First fiscal year in the series	€ 41,217,946 Balance sheet total 2023: € 41,217,946 ▼ 11% vs 2022 (€ 46,249,347) Unchanged	€ 39,360,952 Balance sheet total 2024: € 39,360,952 ▼ 5% vs 2023 (€ 41,217,946) Unchanged	€ 45,627,006 Balance sheet total 2025: € 45,627,006 ▲ 16% vs 2024 (€ 39,360,952) Unchanged	▲ 16%
Employees (FTE)	99.1 Employees (FTE) 2022: 99.1 First fiscal year in the series	100.3 Employees (FTE) 2023: 100.3 ▲ 1.2 vs 2022 (99.1) Unchanged	97.7 Employees (FTE) 2024: 97.7 ▼ 2.6 vs 2023 (100.3) Unchanged	94.7 Employees (FTE) 2025: 94.7 ▼ 3 vs 2024 (97.7) Unchanged	▼ 3

Key figures of AMGEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to AMGEN?

What happened at AMGEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Sara Schaufelberger stepped down as director. NBB
2030 Roman Stampfli stepped down as director. NBB
2029 Paraskevi Florou stepped down as director. NBB
Jul 3, 2026 New annual accounts for financial year 2025: profit of € 6 million (▲ 6% vs 2024). Source: NBB ↗
2024 Sara Schaufelberger became a director. NBB
2024 Roman Stampfli became a director. NBB
2023 Paraskevi Florou became a director. NBB
Jun 14, 1990 New establishment in Machelen (Brab.). KBO

In short

From € 5 million profit in 2022 to € 6 million profit in 2025.

Paid € 7.9 million in corporate taxes since 2022.

Best year ever: 2025, with € 6 million profit.

Paid out € 30.5 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Amgen Worldwide Holdings BV 100%

Amgen International AG 0%

AMGEN

The shares are held by Amgen Worldwide Holdings BV (100%) and Amgen International AG (0%).

Directors

According to the 2025 annual accounts

Sara Schaufelberger

Managing director

since 2024 · until 2030

Paraskevi Florou

Director

since 2023 · until 2029

Roman Stampfli

Director

since 2024 · until 2030

Shareholders

Amgen Worldwide Holdings BV

100%

Amgen International AG

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Telecomlaan 5-7

1831 Machelen (Brab.)

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

AON BELGIUM

€ 393.1 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0439.652.401

VAT number

BE 0439.652.401

Registered office

Telecomlaan 5-7, 1831 Machelen (Brab.)

Names & denominations

AMGEN

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

21 December 1989

Peppol

Active · Active since 10 Sept 2025

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

AMGEN

Financials

What happened to AMGEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions